Autism Research and Treatment / 2012 / Article / Tab 4

Research Article

Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism

Table 4

Individual clinical global impression ratings over the 12-week study period.

IDLanguage Expressive*Receptive Language*Social Skills*
BaselineWeek 6Week 12BaselineWeek 6Week 12BaselineWeek 6Week 12

17.06.06.06.04.06.07.04.0
27.06.56.05.54.04.04.04.0
34.01.52.02.01.52.04.02.01.0
45.05.04.04.02.02.04.03.02.0
54.03.0 3.03.02.0 2.04.02.0
66.0 4.06.0 4.05.04.0
75.02.05.01.55.01.5

𝑃 value*0.0420.0230.0270.0660.0660.066

*Decreasing scores reflect increased improvement.
𝑃 values represent the results of the differences between baseline values and 6 and 12-month values using the Wilcoxon Signed Ranks Test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.